Psychopharmacology 2023 – What is New, What is Coming? | Dr. Thomas Raedler

2023 APA Scientific Conference

50% of survey complete.

Please click "Next" if you did not attend this session

Question Title

* The session met the stated learning objectives:

	Strongly disagree	Disagree	Somewhat disagree	Neither agree or disagree	Somewhat agree	Agree	Strongly agree
Better understanding of newly approved psychotropic medications	Better understanding of newly approved psychotropic medications Strongly disagree	Better understanding of newly approved psychotropic medications Disagree	Better understanding of newly approved psychotropic medications Somewhat disagree	Better understanding of newly approved psychotropic medications Neither agree or disagree	Better understanding of newly approved psychotropic medications Somewhat agree	Better understanding of newly approved psychotropic medications Agree	Better understanding of newly approved psychotropic medications Strongly agree
Better understanding of new indications for previously approved psychotropic medications	Better understanding of new indications for previously approved psychotropic medications Strongly disagree	Better understanding of new indications for previously approved psychotropic medications Disagree	Better understanding of new indications for previously approved psychotropic medications Somewhat disagree	Better understanding of new indications for previously approved psychotropic medications Neither agree or disagree	Better understanding of new indications for previously approved psychotropic medications Somewhat agree	Better understanding of new indications for previously approved psychotropic medications Agree	Better understanding of new indications for previously approved psychotropic medications Strongly agree
Better understanding of existing pharmacological treatment-challenges	Better understanding of existing pharmacological treatment-challenges Strongly disagree	Better understanding of existing pharmacological treatment-challenges Disagree	Better understanding of existing pharmacological treatment-challenges Somewhat disagree	Better understanding of existing pharmacological treatment-challenges Neither agree or disagree	Better understanding of existing pharmacological treatment-challenges Somewhat agree	Better understanding of existing pharmacological treatment-challenges Agree	Better understanding of existing pharmacological treatment-challenges Strongly agree

Question Title

* Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):

	Strongly disagree	Disagree	Somewhat disagree	Neither agree or disagree	Somewhat agree	Agree	Strongly agree
The session was educationally relevant.	The session was educationally relevant. Strongly disagree	The session was educationally relevant. Disagree	The session was educationally relevant. Somewhat disagree	The session was educationally relevant. Neither agree or disagree	The session was educationally relevant. Somewhat agree	The session was educationally relevant. Agree	The session was educationally relevant. Strongly agree
The presenter was educationally effective.	The presenter was educationally effective. Strongly disagree	The presenter was educationally effective. Disagree	The presenter was educationally effective. Somewhat disagree	The presenter was educationally effective. Neither agree or disagree	The presenter was educationally effective. Somewhat agree	The presenter was educationally effective. Agree	The presenter was educationally effective. Strongly agree
The session provided interactive opportunities.	The session provided interactive opportunities. Strongly disagree	The session provided interactive opportunities. Disagree	The session provided interactive opportunities. Somewhat disagree	The session provided interactive opportunities. Neither agree or disagree	The session provided interactive opportunities. Somewhat agree	The session provided interactive opportunities. Agree	The session provided interactive opportunities. Strongly agree
The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Strongly disagree	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Disagree	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Somewhat disagree	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Neither agree or disagree	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Somewhat agree	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Agree	The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice Strongly agree

Comments:

Question Title

* Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):

	Strongly disagree	Disagree	Somewhat disagree	Neither agree or disagree	Somewhat agree	Agree	Strongly agree
The session and presenter did NOT have commercial or other inappropriate bias.	The session and presenter did NOT have commercial or other inappropriate bias. Strongly disagree	The session and presenter did NOT have commercial or other inappropriate bias. Disagree	The session and presenter did NOT have commercial or other inappropriate bias. Somewhat disagree	The session and presenter did NOT have commercial or other inappropriate bias. Neither agree or disagree	The session and presenter did NOT have commercial or other inappropriate bias. Somewhat agree	The session and presenter did NOT have commercial or other inappropriate bias. Agree	The session and presenter did NOT have commercial or other inappropriate bias. Strongly agree

Comments:

Question Title

* How did you attend the session?

In-person

Virtually

Question Title

* Please provide any other comments you would like to share: